Details of the responses from the ENUP/BAUP prostate biopsy processing survey of laboratories in Europe
are presented in the following 23 tables:
See download at end of page
1. Who performs prostate biopsy procedure?
2. How many cores are most commonly taken from each patient?
3. How are cores submitted to the laboratory?
4. How many cores are most commonly received in each container or cassette?
5. Are biopsies from the anterior gland (transition zone) routinely taken?
6. Are right and left biopsies identified separately when received in laboratory?
7. Which fixative is routinely used in your laboratory?
8. How many cores are most commonly processed in each paraffin block?
9. Does biopsy taker use any special techniques for flattening cores?
10. Does laboratory staff use any special techniques for flattening cores prior to embedding?
11. Does laboratory staff use any special techniques for flattening cores during embedding?
12. Are cores inked to make them more visible at embedding and cutting stages?
13. Are cores inked with separate colours to identify site of biopsy?
14. How many initial H&E levels are examined from each block?
15. How many H&E sections are examined from each level?
16. Are unstained spare sections for immunohistochemistry retained while cutting initial sections?
17. How are unstained spare sections for potential immunohistochemistry retained?
18. From how many levels are unstained spare sections retained for potential immunohistochemistry?
19. For how many months after reporting are unstained spare sections retained?
20. Which immunohistochemical markers are used to distinguish prostate cancer from benign prostate glands?
21. Is immunohistochemistry routinely performed on all prostate biopsies?
22. How are immunohistochemical markers applied when multiple antibodies are used on a core?
23. How are multiple antibodies applied on a single section?